CD8A and neoplasm: As expected, the proportion of CD3+ CD8+ T cells in the tumor tissues of mice treated with APm/Ce6/HIF+US was 64.5%, representing an 18.0% increase compared with that in mice treated with PBS (46.5%) (Figure 7J).